Reviparin Sodium

Drug #1667

Reviparin sodium is a low molecular weight heparin with anticoaggulant activity. Reviparin sodium is used in the prevention of postoperative venous thrombo-embolism.

← Previous drug Next drug →

Primary Characteristics

Non-proprietary name: Reviparin Sodium.

Pharmacokinetics

None recorded.

Indications

Reviparin Sodium is primarily indicated in conditions like Prophylaxis of deep vein thrombosis (espacilly in surgical patients).

Contraindications

Reviparin Sodium is contraindicated in conditions like Haemorrhage, Bleeding, Lumbar puncture headache.

Dosage

Reviparin Sodium's dosage details are as follows:

Dose	Single Dose	Frequency	Route	Instructions
Adult Dosage
0.25 ml	0.25 ml	—	SC	Administer daily at least 2 hrs prior to surgery.
Paediatric Dosage (20kg)
No data.
Neonatal Dosage (3kg)
No data.

Drug Interactions

5 interactions

Always consult your physician for the change of dose regimen or an alternative drug of choice that may strictly be required.

Side Effects

Reviparin Sodium is known to cause more or less tolerable side effects which are usually transient. These include Hemorrhage, Osteoporosis, Thrombocytopenia.

Warnings / Precautions

Reviparin must not be administered intramuscularly. Other medications requiring intramuscular injections should be avoided during reviparin treatment. Plasma potassium should be measured in patients at risk before starting heparin therapy and monitored regularly thereafter, particularly if treatment is prolonged beyond about seven days.

Available Brands

None recorded.

Drug Classification

1.10.2 — Anticoagulants/Platelet deaggregators